Publications & working papers
One product, many patents: Imperfect intellectual property rights in the pharmaceutical industry. Selected for presentation at NBER Summer Institute (Innovation)
Strategic entry in regulated markets with Jennifer Kao
Innovation and cross-market spillovers in “big” firms with Matthew Grennan and Mara Lederman
Drug repurposing during the COVID-19 pandemic: Lessons for expediting drug development and access with Wesley Greenblatt and Jennifer Kao, Health Affairs (2023)
Research in progress
Standing on the patents of giants: Concentrated intellectual property rights and cumulative innovation
Competing risks and “missing” medical innovation with Alexander Olssen
Does going public affect pharmaceutical innovation? Evidence from clinical trials with Jennifer Kao
Other writing
Industry, universities, and intellectual property, white paper prepared for the NBER-IFS International Network on the Value of Medical Research